These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33707959)

  • 1. In vitro and in vivo Effect of Antimicrobial Agent Combinations Against Carbapenem-Resistant
    Liu E; Jia P; Li X; Zhou M; Kudinha T; Wu C; Xu Y; Yang Q
    Infect Drug Resist; 2021; 14():917-928. PubMed ID: 33707959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant
    Wu Y; Yu W; Chu X; Zhang J; Jia P; Liu X; Zhu Y; Xu Y; Yang Q
    Microbiol Spectr; 2024 Jun; 12(6):e0010724. PubMed ID: 38712934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
    Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
    Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro.
    Zhang J; Yu L; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
    Ann Palliat Med; 2019 Nov; 8(5):622-631. PubMed ID: 31735038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.
    Erdem F; Abulaila A; Aktas Z; Oncul O
    Antimicrob Resist Infect Control; 2020 May; 9(1):70. PubMed ID: 32430058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Synergistic Combinations in Extended and Pan-Drug Resistant (XDR and PDR) Whole Genome Sequenced
    Quraini MA; Jabri ZA; Sami H; Mahindroo J; Taneja N; Muharrmi ZA; Busaidi IA; Rizvi M
    Microorganisms; 2023 May; 11(6):. PubMed ID: 37374911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of NDM-5-Producing Carbapenem-Resistant
    Li Q; Zhu J; Kang J; Song Y; Yin D; Guo Q; Song J; Zhang Y; Wang S; Duan J
    Infect Drug Resist; 2020; 13():3075-3089. PubMed ID: 32943891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant
    Al-Quraini M; Rizvi M; Al-Jabri Z; Sami H; Al-Muzahmi M; Al-Muharrmi Z; Taneja N; Al-Busaidi I; Soman R
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhou C; Wang Q; Jin L; Wang R; Yin Y; Sun S; Zhang J; Wang H
    Front Microbiol; 2020; 11():533209. PubMed ID: 33193122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antibacterial activity of ceftazidime-avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae.
    Tüzemen NÜ; Önal U; Merdan O; Akca B; Ener B; Özakın C; Akalın H
    Sci Rep; 2024 Jul; 14(1):17567. PubMed ID: 39080317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing
    Allander L; Vickberg K; Lagerbäck P; Sandegren L; Tängdén T
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36421290
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Li X; Chen Z; Jiao J; Wang S; Wang Y; Wu W; Yang H; Lou H
    Expert Rev Anti Infect Ther; 2023 Jan; 21(1):91-98. PubMed ID: 36433637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant
    Abdul-Mutakabbir JC; Yim J; Nguyen L; Maassen PT; Stamper K; Shiekh Z; Kebriaei R; Shields RK; Castanheira M; Kaye KS; Rybak MJ
    Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356801
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae.
    Poirel L; Kieffer N; Nordmann P
    J Antimicrob Chemother; 2016 Jan; 71(1):156-61. PubMed ID: 26416781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
    Gheitani L; Fazeli H; Moghim S; Nasr Isfahani B
    Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):70-74. PubMed ID: 29412797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
    Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
    Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and/or NDM-producing
    Erturk Sengel B; Altinkanat Gelmez G; Soyletir G; Korten V
    J Chemother; 2020 Sep; 32(5):237-243. PubMed ID: 32228228
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant
    Bakthavatchalam YD; Shankar A; Muthuirulandi Sethuvel DP; Asokan K; Kanthan K; Veeraraghavan B
    Future Sci OA; 2020 Feb; 6(4):FSO461. PubMed ID: 32257374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.